RPL7AP66

Across TCGA pan-cancer cohorts, RPL7AP66 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated RPL7AP66 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RPL7AP66 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL7AP66 expression acts as an unfavorable survival marker, although some lineages such as SKCM and MESO show a favorable association.

ACC, KIRP, and SKCM are the cancer types where RPL7AP66 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Median	All	0.264	0.624	<.001	84	view →
KIRP	DFS	Tertile	All	0.533	0.832	<.001	66	view →
SKCM	OS	Median	III,IV	0.787	0.618	.001	50	view →
UCEC	DFS	Median	All	0.493	0.780	<.001	50	view →
OV	OS	Median	All	0.266	0.378	.001	40	view →
SARC	DFS	Median	All	0.531	0.685	<.001	26	view →
LUAD	OS	Median	III,IV	0.309	0.664	<.001	22	view →
LIHC	DFS	Median	All	0.473	0.609	.001	21	view →
MESO	DFS	Tertile	III,IV	0.671	0.138	.006	18	view →
KIRC	DFS	Tertile	All	0.729	0.517	.001	18	view →
THCA	OS	Median	All	1.000	0.985	.014	16	view →
CESC	DFS	Quartile	II,III,IV	0.821	0.304	.008	14	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

RPL7AP66–ACC (DFS)

Open the ACC breakdown →